Cellectar Biosciences, Inc. (CLRB) Social Stream
CELLECTAR BIOSCIENCES INC (CLRB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CELLECTAR BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-13 | 2 | $10 | $3 | $5.375 | $2.83 | 89.93% |
| 2022-03-21 | 3 | $10 | $3 | $5.375 | $2.83 | 89.93% |
| 2022-04-07 | 5 | $10 | $3 | $5.3 | $2.83 | 87.28% |
| 2022-05-11 | 5 | $10 | $2 | $5.1 | $2.83 | 80.21% |
| 2022-06-03 | 5 | $10 | $1.25 | $4.95 | $2.83 | 74.91% |
| 2022-08-05 | 5 | $55 | $12.5 | $37.5 | $2.83 | 1225.09% |
| 2022-09-22 | 5 | $50 | $12.5 | $35.9 | $2.83 | 1168.55% |
| 2022-11-04 | 5 | $50 | $12 | $25.9 | $2.83 | 815.19% |
| 2023-02-28 | 5 | $25 | $4 | $12.6 | $2.83 | 345.23% |
| 2023-05-04 | 4 | $20 | $7 | $13.25 | $2.83 | 368.2% |
| 2023-06-12 | 4 | $20 | $7 | $13 | $2.83 | 359.36% |
| 2023-08-16 | 4 | $20 | $7 | $12.5 | $2.83 | 341.7% |
| 2023-11-02 | 4 | $20 | $8 | $13.666 | $2.83 | 382.9% |
The Trend in the Analyst Price Target
CLRB's average price target has moved up $7.69 over the prior 32 months.
CLRB reports an average of 648.88% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 5 | 25 | 4 | 12.60 | 1.56 | 707.69% |
| 2023-05-04 | 4 | 20 | 7 | 13.25 | 1.48 | 795.27% |
| 2023-05-04 | 4 | 20 | 7 | 13.00 | 1.48 | 778.38% |
| 2023-08-16 | 4 | 20 | 7 | 12.50 | 1.64 | 662.2% |
| 2023-09-11 | 4 | 20 | 7 | 12.00 | 2.17 | 453% |
CLRB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CLRB's average broker recommendation rating improved by 0 over the prior 42 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CELLECTAR BIOSCIENCES INC's variance in analysts' estimates is lower than -1660.75% of them.
- CLRB has a greater upside potential (average analyst target price relative to current price) than 1664.14% of all US stocks.
- In terms of how CELLECTAR BIOSCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 286.87% of that group.
- In the context of Healthcare stocks, CELLECTAR BIOSCIENCES INC's average analyst price target is greater than 420.78% of them.
Stocks similar to CELLECTAR BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CAPR, LPTX, and PULM.
View All Top Stocks by Price Target
What is the outlook for CLRB? Use POWR Ratings for clearer insight into price direction.